Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Ono Pharmaceutical Co Ltd today announced that it has entered into a license agreement with NEXI Inc for NXI NXI is a firstinclass antibody drug candidate targeting ONCOKINE which is a cancer
Eisai Co Ltd announced today that its US subsidiary Eisai Inc has decided to invest up to million USD in CN Diagnostics LLC to support CNs efforts to expand the availability accessibility affordability
Biogen Inc announced interim month biomarker data from the initial participants in the openlabel
CASI Pharmaceuticals Inc a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products and BioInvent International AB
Lipella Pharmaceuticals Inc a clinicalstage biotechnology company addressing serious diseases with significant unmet need today announces that the US Food and Drug Administration
ANEW MEDICAL INC a USbased biotechnology company focused on developing cell and gene based treatments to affect aging and agerelated diseases announced that is has been granted and issued a patent
Cyprium Therapeutics Inc a majorityowned subsidiary of Fortress Biotech Inc today announced that the National Institute of Neurological Disorders and Stroke of the National Institutes of Health
Telix today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc its advanced cyclotronbased isotope production platform manufacturing plant and stockpile of ultrapure rare metals required for consum...
CARsgen Therapeutics Holdings Limited a company focused on innovative CAR Tcell therapies for the treatment of hematologic malignancies and solid tumors announces that today the National Medical
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology metabolic autoimmune
